Daniel J Lavery, PhD, is the Chief Scientific Officer of the Loulou Foundation, and Director of the CDKL5 Program of Excellence in the Orphan Disease Center at the Perelman School of Medicine, University of Pennsylvania. Dan trained at Johns Hopkins University, Mount Sinai School of Medicine, and the University of Geneva, Switzerland. He is the author or co-author on over 25 primary research articles, reviews, and book chapters, and is an inventor on several patents.
Dan has conducted research in neuroscience and CNS disorders for over twenty years, in pharma, biotech, and academia, with a focus on using systems biology and ‘omics-scale data mining to identify biological pathways and mechanisms implicated in disease pathology. Before joining the Loulou Foundation, he directed discovery and systems biology programs in Huntington’s disease therapeutic research at CHDI, a private foundation dedicated to HD therapeutic development.